You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-17. Route of administration of primary drug as main reason for asking treatment among new and all outpatient clients in 2005 [see all tables in this series...]

Part (v) Percentage amongst all clients with opioids as primary drug

Country		Inject	Smoke/inhale	Eat/drink	Sniff	Others	Base (known status)	Status unknown
Bulgaria		77.1	7.8	0.3	11.4	3.4	765	32
Czech Republic		83.1	6.5	8.1	1.9	0.3	629	7
Denmark		19.0	22.4	55.4	3.3	0.0	1467	205
Germany		45.2	17.9	31.6	3.8	1.5	20032	17579
Ireland		48.4	45.8	5.7	0.0	0.0	2209	78
Greece		45.0	11.9	0.4	42.8	0.0	1846	11
Spain	(1)	23.0	63.4	4.7	4.9	4.0	19792	1224
France		30.6	13.9	8.8	46.3	0.4	4687	2026
Italy		61.4	34.7	0.6	3.1	0.2	26842	22
Cyprus		68.6	28.0	0.0	3.4	0.0	118	0
Lithuania		98.3	0.0	1.5	0.2	0.0	4311	0
Luxembourg		66.5	27.6	5.9	0.0	0.0	185	5
Hungary		55.5	17.2	18.3	8.6	0.4	1474
Malta		75.1	16.7	0.3	7.1	0.8	378	6
Netherlands	(2)	9.0	73.4	14.2	1.9	1.5	2200	476
Slovakia		78.4	14.8	2.7	3.6	0.4	473	4
Finland		82.5	0.7	8.7	7.9	0.1	699	19
Sweden		47.2	10.5	40.2	1.3	0.8	371	10
United Kingdom	(3)	42.1	41.3	10.1	1.0	5.5	53977	11393
Total		45.2	36.6	10.6	4.6	3.0	142455	33097

Notes:

Only countries where there are clients reported with opiates as primary drug are shown.

(1) Data from Spain refer to 2004.

(2) Data refer to outpatient treatment centres and low-threshold agencies.

(3) Data refer to collection period between 01.04.2004 and 31.03.2005.

See also 'Table TDI-110' for cocaine CIH and crack route of administration distribution, and 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - TDI - outpatient treatment centres.